Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006.

2.50
Hdl Handle:
http://hdl.handle.net/10541/620825
Title:
Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006.
Authors:
Long, G; Robert, C; Arance, A; Blank, C; Ribas, A; Lorigan, Paul C ( 0000-0002-8875-2164 ) ; Mortier, L; Schachter, J; Middleton, M; Neyns, B; Sznol, M; Zhou, H; Ebbinghaus, S; Ibrahim, N; Steven, N
Affiliation:
Melanoma Institute Australia, Medical Oncology, Sydney
Citation:
Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006. 2017, 72:S128 Eur J Cancer
Journal:
European Journal of Cancer
Issue Date:
Feb-2017
URI:
http://hdl.handle.net/10541/620825
DOI:
10.1016/S0959-8049(17)30500-2
Additional Links:
http://linkinghub.elsevier.com/retrieve/pii/S0959804917305002
Type:
Meetings and Proceedings
Language:
en
ISSN:
09598049
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorLong, Gen
dc.contributor.authorRobert, Cen
dc.contributor.authorArance, Aen
dc.contributor.authorBlank, Cen
dc.contributor.authorRibas, Aen
dc.contributor.authorLorigan, Paul Cen
dc.contributor.authorMortier, Len
dc.contributor.authorSchachter, Jen
dc.contributor.authorMiddleton, Men
dc.contributor.authorNeyns, Ben
dc.contributor.authorSznol, Men
dc.contributor.authorZhou, Hen
dc.contributor.authorEbbinghaus, Sen
dc.contributor.authorIbrahim, Nen
dc.contributor.authorSteven, Nen
dc.date.accessioned2018-02-15T21:52:40Z-
dc.date.available2018-02-15T21:52:40Z-
dc.date.issued2017-02-
dc.identifier.citationAntitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006. 2017, 72:S128 Eur J Canceren
dc.identifier.issn09598049-
dc.identifier.doi10.1016/S0959-8049(17)30500-2-
dc.identifier.urihttp://hdl.handle.net/10541/620825-
dc.language.isoenen
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0959804917305002en
dc.rightsArchived with thanks to European Journal of Canceren
dc.titleAntitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMelanoma Institute Australia, Medical Oncology, Sydneyen
dc.identifier.journalEuropean Journal of Canceren
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.